Skip to main content

Table 3 Current development status of NFκB pathway inhibitors. (Investigational Drugs DataBase, Nov 15 2005 [106], advanced search by activity field on Nuclear factor kappa B inhibitor)

From: Applied information retrieval and multidisciplinary research: new mechanistic hypotheses in Complex Regional Pain Syndrome

Development status No. of drugs
Discovery Research 22
Clinical (unspecified) 1
Phase I clinical trials 4
Phase II clinical trials 4
Phase III clinical trials 0
Pre-registered 0
Registered 0
Launched 1 bortezomib
Research tools 1
Suspended 0
Withdrawn 0
No development reported 4
Discontinued 4